
Understanding Hermansky-Pudlak Syndrome 9: A Genetic Perspective
Explore Hermansky-Pudlak Syndrome 9, a genetic disorder with distinct challenges. Genetic testing aids in early diagnosis, personalized treatment, and family planning.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore Hermansky-Pudlak Syndrome 9, a genetic disorder with distinct challenges. Genetic testing aids in early diagnosis, personalized treatment, and family planning.

Incomplete division of the forebrain gives rise to facial differences, intellectual disability and seizures, with severity and inheritance patterns varying widely.

Repeat molar pregnancies have been linked to NLRP7 and KHDC3L mutations found by next-generation sequencing, which also supports embryo screening before implantation.

Severe hydrocephalus, polydactyly and craniofacial anomalies mark this autosomal recessive disorder linked to HYLS1; carrier and prenatal screening options are described.

Biliverdin, a green bile pigment, normally becomes bilirubin; in hyperbiliverdinemia that step is impaired, so it builds up and may cause jaundice and fatigue.

When hepatic triglyceride lipase is deficient, cholesterol and triglycerides rise, raising the risk of early atherosclerosis. Gene testing guides diagnosis and care.

Severe developmental effects in HPMRS3 trace to homozygous PGAP2 mutations, which disturb protein modification. Testing supports diagnosis and prognosis.

Uromodulin gene mutations underlie HNFJ3, in which uric acid builds up and kidney function declines from childhood; gout risk and testing are covered.